Cite

HARVARD Citation

    Yang, Y. et al. (2016). Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses. BMC cancer. 16 (1), pp. 1-10. [Online]. 
  
Back to record